Case Report Sclerotherapy of Intraoral Superficial Hemangioma Resmije Ademi Abdyli, 1 Yll Abdyli, 2 Feriall Perjuci, 1 Ali Gashi, 1 Zana Agani, 1 and Jehona Ahmedi 1 1 Department of Oral Surgery, Medical Faculty, University of Prishtina, Dental Branch, 10000 Prishtina, Kosovo 2 Medical Faculty, University of Prishtina, Dental Branch, 10000 Prishtina, Kosovo Correspondence should be addressed to Yll Abdyli; yllabdyli10@gmail.com Received 2 September 2016; Revised 12 October 2016; Accepted 18 October 2016 Academic Editor: Giuseppe Colella Copyright © 2016 Resmije Ademi Abdyli et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. eir most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause the damage of blood vessels followed by their obliteration. e objective of the study was to describe the facility of application and evaluate the efficiency of sclerotherapy with aethoxysklerol 1%. Method. e case presented with intraoral submucosal hemangioma of the cheek was treated by intralesional injection of aethoxysklerol 3% diluted in water for injections at a 4 : 1 ratio (0.75%) at the first appointment and 3 : 1 (1%) at the second appointment. e effect of sclerotherapy was evaluated on the following visits in time intervals of two weeks. Results. e hemangioma disappeared without complications aſter the second injection of aethoxysklerol 1%. e successful results of the study were comparable to the data of literature with variations according to the used sclerosant agent, its concentration, the number of injections, and the intervals between each session. Conclusion. Since sclerotherapy is a very effective, inexpensive, and easy-to-apply treatment, it should be the treatment of choice, especially for intraoral superficial hemangiomas. 1. Introduction Hemangioma is a vascular neoplasm or a vascular anomaly due to proliferation of blood vessels. ey occur anywhere in the body, but skin and oral mucosa in the region of the lips, tongue, and buccal mucosa are most commonly affected. erefore, the dentist or oral surgeon should be informed about their clinical aspect, diagnosis, and therapy [1–3]. e clinical aspect of oral hemangiomas depends on their location and depth. Usually hemangiomas present as blood- filled asymptomatic swellings or red/bluish-purple discol- orations, but their progressive growth can increase the like- lihood of local traumatic injuries followed by unexpected bleeding [4–7]. e size of hemangiomas is variable, ranging from a few millimeters to several centimeters in the form of a macule, papule, nodule, or tumor, with elastic or fibrous consistency [8]. In order to obtain a definite diagnosis of vascular mal- formations (of suspected hemangioma), different clinical examination methods can be implemented, including digital compression and diascopy [6, 7] and other supplementary imaging tests such as ultrasonography with Doppler and MRI [9, 10]. Various modalities have been used in the treatment of hemangiomas, depending on their location, size and depth, evolution of injury, and involvement of adjacent structures [8, 10]. e gold standard for hemangioma treatment, especially for smaller circumscribed lesions and peripheral heman- giomas, is conventional surgical excision [3, 11]. However, complications that arise from conventional invasive surgical procedures such as excessive postoperative bleeding com- pelled the use of other different therapeutic alternatives including systemic corticosteroids, laser therapy, cauteriza- tion, cryotherapy, radiotherapy, and sclerotherapy [4, 12–14]. ese modes of treatment can be applied individually or in concert. e Objective. e Objective of the study was to describe the facility of the application of sclerosing agents and evaluate the Hindawi Publishing Corporation Case Reports in Dentistry Volume 2016, Article ID 4320102, 5 pages http://dx.doi.org/10.1155/2016/4320102